July 25, 2016

Subscribe to Maine Medicine eNewsletters
Manage Your Subscriptions
Email our Editor...
Maine Medical Association Home Page
. Search back issues
. Plain Text Version
Printer Friendly

Opioid Prescribing Limits Begin Friday, July 29th

MMA members are reminded that one element of Maine's new law limiting opioid medication prescribed for pain becomes effective this coming Friday, July 29th.  Subject to the exceptions set forth in the law, a patient may not be prescribed any combination of opioid medication in an aggregate amount in excess of 100 morphine milligram equivalents (MMEs) of opioid medication per day.

The exclusions in the law include prescribing opioid medication to a patient for:

  1. Pain associated with active and aftercare cancer treatment;
  2. Palliative care, as defined in Title 22, section 1726, subsection 1, paragraph A, in conjunction with a serious illness, as defined in Title 22, section 1726, subsection 1, paragraph B;
  3. End-of-life and hospice care;
  4. Medication-assisted treatment for substance use disorder; or
  5. Other circumstances determined in rule by the Department of Health and Human Services pursuant to Title 22, section 7254, subsection 2; and
  6. When directly ordering or administering a benzodiazepine or opioid medication to a person in an emergency room setting, an inpatient hospital setting, a long-term care facility or a residential care facility.

Although the requirement to check the Prescription Monitoring Program (PMP) for a new script does not take effect until January 1, 2017, it would not be possible to know what opioid medication the patient may be receiving from other prescribers without checking the PMP.   So, in effect, the PMP mandate should be observed beginning July 29th if a prescriber is not already routinely checking the PMP for new scripts for an opiate based medication.  On January 1, 2017, the PMP mandate will include a first script written for a benzodiazepine in addition to an opioid.


Other information on the new law can be found on the MMA website at www.mainemed.com. MMA attorneys are available to present CME programs on the new law.  If you are interested in a presentation at your practice or facility contact MMA's CME Coordinator Gail Begin at gbegin@mainemed.com or EVP Gordon Smith at gsmith@mainemed.com or by calling Gordon at 215-7461.





Department of Justice Challenges Proposed Health Plan Mergers

Last week, the United States Department of Justice announced that it would file litigation seeking to block the proposed mega-mergers of Anthem and CIGNA and Aetna and Humana.   MMA, the AMA, and several other medical societies had asked the Justice Department to block the mergers based upon standard anti-trust principles.  While this action by the Justice Department will not, in and of itself, halt the mergers, observers believe that Anthem and CIGNA may not have the desire to go forward in the face of federal opposition.  It is possible that Aetna and Humana may continue with their plans, but if successful, the merger of these companies would not have as big an impact in Maine as an Anthem-CIGNA merger.

"Following substantial input from our members, the MMA Board voted to oppose the mergers and we were pleased to be able to talk with Justice Department investigators last January and convey to them the belief of our members that the mergers would not be in the best interest of patients or health professionals of all types," said Gordon Smith, MMA EVP following the announcement.   "We are very appreciative of the work of the AMA and several other state medical societies which joined in the opposition to these mega-mergers and we are very gratified that the Justice Department, following its investigation, ultimately agreed with our position."

The annual research by the AMA on the consolidation of insurance markets by the national plans also was a very important element in the Justice Department investigation.   The health insurance market in Maine was one of the markets that showed significant consolidation and concentration of the health insurance market if the Anthem-CIGNA merger were approved.

You can read the AMA's press statement on the recent DOJ action here.

MMA thanks those members and practice managers who provided input to both the Attorney General's office and the Justice Department.

An AMA Viewpoints post by AMA President Andrew W. Gurman, MD

Prospects for major health insurance consolidation took a major hit when the U.S. Department of Justice (DOJ) and a number of states filed antitrust lawsuits Thursday to block both the Aetna, Inc.-Humana, Inc. and Anthem, Inc.-Cigna Corp. mergers.  The DOJ asserted that the mergers would substantially lessen competition.

When something comes up that could negatively affect our patients and the quality and affordability of the care they receive, physicians take the lead and engage policymakers.  With the same drive that put us through late nights in med school, carried us through the intensity of our residencies and continues to push us every day to go the extra mile for our patients and their families, we took these mergers on—and our voices were heard.

Creating even larger goliaths would be unacceptable—and I said so in a public statement today. Federal and state officials have a strong obligation to enforce antitrust laws to protect patients by ensuring a competitive marketplace that operates in patients' best interests.

The DOJ's action is a significant step toward the kind of marketplace that doesn't put the insurers first but rather puts patients first. And that's what we as physicians care about most.

Physicians fight to protect patients
Both mergers were announced in July of last year. My colleague, Immediate-past President, Steven J. Stack, MD, responded swiftly with a statement detailing how the mergers would increase health insurance market concentration and reduce competition in both the market for the sale of health insurance and in the market in which health insurers purchase physician services, ultimately resulting in further patient injury due to a decrease in the quality and quantity of available physician services. Neither development is something we as physicians can allow.

At the outset of the DOJ and state investigation of these mergers, the AMA was armed by our annual market studies on competition in health insurance and by an AMA study published in a leading academic journal establishing that a previous merger—United Health Group Inc.'s 2008 merger with Sierra health services—resulted in higher premiums.

Over the course of the next year, we physicians took it upon ourselves to stand up against the mergers of these powerful insurers by submitting testimony in congressional and state proceedings and preparing memoranda to state and federal officials investigating the mergers. In this effort, the AMA joined with state medical societies and gained the assistance of influential lawyers and economists to gather the evidence and present the arguments against the mergers to the DOJ, state attorneys general and state insurance departments.

I testified at a congressional hearing examining the proposed mergers and the impact they would have on competition in September, urging them to closely scrutinize the mergers and utilize enforcement tools at their disposal to protect patients and preserve competition.

Two weeks before, my colleague, Barbara L. McAneny, MD, who is a member of the AMA board of trustees, testified before Congress with a similar message. Together, we carried that message into the 2015 AMA Interim Meeting, where the AMA House of Delegates passed new policy that emphasized the need for active opposition to consolidation in the health insurance industry that could result in anticompetitive markets.

In December, the AMA identified the "big 17"—states where the mergers would have the greatest impact—and formed a coalition to block the mergers. A survey was developed relating to the monopsony issues raised by the proposed mergers and sent out to physicians in those states. Physician feedback was included as the big 17 coalition drafted letters sent to the DOJ.

What's important is that the medical community came together under this coalition, not with the intention of fighting the goliath companies that would be formed by the mergers, but rather to prevent them from happening. The physician voice is stronger when we can all come together under the same leadership.

As the letters were drafted and sent, we continued to lay on the pressure and the argument of the coalition became stronger and harder to refute.

Last month, the California Department of Insurance issued a letter urging the DOJ to block the Anthem-Cigna merger. The insurance commissioner based this conclusion on a March 29 public hearing that included testimony and written comments from the public, patient advocates, experts on health insurance mergers, and both the AMA and the California Medical Association (CMA).

Jointly with the CMA, we filed a comprehensive, evidence-based analysis (log in) explaining why the merger should be blocked. At the hearing, our top antitrust attorney, testified that the consequences of the proposed merger would have long-term consequences for health care access, quality and affordability.

Similarly, Missouri, with our input, took a hard stand against Aetna's acquisition of Humana in May when the Missouri Department of Insurance issued a cease-and-desist order preventing the companies from doing any post-merger business in Missouri's Medicare Advantage markets and some commercial insurance markets.

All of these efforts raised awareness and ultimately led to this moment today—on the cusp of a win for our patients.

Today's news is especially gratifying. The DOJ /State suit against Anthem-CIGNA incorporates the AMA's concerns that the merger would result in a health insurer buyer "monopsony" power over the physician marketplace. The suit against Aetna adopts the AMA's long-held and strenuously argued view that Medicare Advantage is a separate market that would suffer antitrust injury by the proposed Aetna-Humana merger. Finally, the AMA is thankful the state Attorneys General, like Florida, who listened to the physicians' concerns and joined the lawsuits.

The fight isn't over yet
A merger of this magnitude would compromise physicians' ability to advocate for their patients—something we consider an integral part of our place in society. In practice, market power allows insurers to exert control over clinical decisions, which undermines our relationships with patients and eliminates crucial safeguards of patient care.

On the other hand, competition can lower health insurance premiums, enrich customer service and spur inventive ways to improve quality and lower costs. Patients benefit when they can choose from many different insurers that are competing for their business by offering coverage that patients want and at competitive prices.

The suit filed by the DOJ is not the end—yet. Both companies have stated that they plan to fight the battle in court and challenge the DOJ lawsuit. The AMA will remain engaged in this process and relentless in our quest to preserve competition in the health insurance marketplace.  

[return to top]

Renewing the Joy & Passion in Medicine - September 9-11, 2016, Bar Harbor, Maine

Maine Medical Association 

163rd Annual Session

September 9-11, 2016

Harborside Hotel, Bar Harbor, ME 


Renewing the Joy & Passion in Medicine

4.5 AMA PRA Category 1 CME Credits TM

Dear Colleagues & Friends:

Recognizing the signs of professional exhaustion is the first step to reintroducing joy and purpose to your career.   Please join your colleagues at this year's Annual Session where you will learn new tools that will help you develop resiliency and renewal in your personal and professional life. 

Click Here to view the full schedule and register for this event.  Bring your family so they can enjoy Mt. Desert Island and Acadia National Park.  

Saturday, Sept. 10, 10:00 a.m.

Tuning Up Your Resilience Program features five physicians who have extensive experience in physician resilience and burn-out prevention. Dr. Jo Shapiro serves as Chief, Div of Otolaryngology, Dept of Surgery, at Brigham and Women's Hospital and is an Associate Professor at Harvard Medical School. She was one of the first woman division chiefs and was recently named as a finalist for the Schwartz Center Compassionate Caregiver Award. Dr. George Dreher, knowing what a habit of mindfulness brought to his life and career at Maine Medical Center, started offering a Mindful Practice of Medicine course and helped create a medical staff subcommittee on practitioner health and resilience. Dr. Christine Hein, who is the Medical Director of the Emergency Medicine Workgroup, knows first-hand the pressure practitioners face in their daily work and how important self-resiliency strategies can be in maintaining ideal standards of care for patients. Ben Tipton, PAC, has been working to improve resiliency at the Mid Coast Hospital and has built a Mindfulness-based Stress reduction program which is providing training for an increasing number of staff. Dr. David Strassler is the chair of the Martin's Point Provider Resiliency Team and has recently undertaken a drive to reduce burdensome paperwork.

Saturday, Sept 10, 12:00 p.m.

Speakers Kevin Mannix and Linda Rota, LSW, will deliver the Saturday noon keynote.  Kevin and Linda have co-authored the book, Weathering Shame, an autobiography on their personal experience growing up with the stigma and shame of 

alcoholism and mental illness. Kevin is a veteran weatherman at WCSH6, Portland and WLBZ 2, Bangor.   His spouse, Linda Rota, LSW, has been a social worker for more than thirty years. She is a 1982 magna cum laud graduate of USM with a B.A. in social welfare and criminal justice. Linda served in the Peace Corps in Sierra Leone, West Africa and trained volunteers on cross-cultural issues. Their book will be available for purchase and book signing.

Sunday, Sept. 11, 9:00 a.m.

Simple Mindfulness Applications to Cultivate Joy & Passion in Work & Life.  Countless demands and rushing about are the norm these days. We live in stressful, chaotic times. The speed of life around us is going faster and faster. This way of living affects our health, our relationships, our families, and the quality of our lives. We do have the ability, the strength, and the stability within us to meet these challenges in a way that brings more happiness into our everyday lives. Mindfulness is a way to access these inner resources.

Nancy Hathaway, M.Ed., LpastC, has been studying and teaching mindfulness for 40 years. She has interned and worked with Jon Kabat-Zinn, Ph.D. in the Mindfulness Stress Clinic at the University of Massachusetts Medical Center and the State of Massachusetts, Department of Corrections. She teaches Mindfulness nationally including Harvard University's Work and Family Center, MIT, hospitals, universities, high schools, colleges, parent groups, and couples courses.  She is an Adjunct Professor in numerous colleges in Maine teaching Mindfulness courses.  She has studied internationally with teachers in the Zen, Vipassana, and Tibetan traditions and holds a Masters in Education degree with a Counseling Psychology track.


7th Annual Silent Auction

Request for Donations

The auction proceeds will benefit the Maine Medical Education Trust (MMET) Scholarship Fund which directly benefits Maine students and relies on this auction as a primary revenue source.


Donation Examples:

Gift Certificates to a Maine restaurant, hotel or resort

Gift Baskets

Weekend or week-long stay at a Condo, Camp or Vacation Home

Concert, Theater or Sporting event tickets

Painting, sculptures, drawing or other artwork

Wine and Spirits

Personal Services (such as spa treatments, car detailing, etc)


Handmade Items

For more information  on donations 

click here.

Stay Connected

Facebook  Twitter   LinkedIn   Pinterest

Maine Medical Association

30 Association Drive

PO Box 190
Manchester, ME 04351



Copyright © 2016. All Rights Reserved.

  [return to top]

2016 Mary Cushman Award Nominations Are Due By August 1st

Nominations for the 2016 Mary F. Cushman Award for Exceptional Humanitarian Service as a Medical Volunteer are due by Monday, August 1st.  The award will be announced at the MMA's Annual Session in September.  The nomination form and brochure with additional information about the award is available at the Annual Session webpage.   [return to top]

Three Useful Changes to Meaningful Use

The Centers for Medicare & Medicaid Services (CMS) has proposed changes to the Meaningful Use program that are intended to relieve physician reporting burdens.  Those changes include reducing the 2016 reporting period to 90 days.

Based on feedback from the health care community, the proposed changes "better support physicians in providing beneficiaries with the right care at the right time," CMS Acting Administrator Andy Slavitt said in a press release.  These changes were detailed in the 2017 Hospital Outpatient Prospective Payment System (OPPS) proposed rule released last week.

What changed?
The AMA continues to drive home the message that the current problems of the Meaningful Use program must not be carried forward—and the changes recently proposed in the OPPS to Meaningful Use are a good start.

Physicians around the country are  hopeful that CMS will also further reduce burdens under Medicare's Merit-based Incentive Payment System (MIPS) when the Medicare Access and CHIP Reauthorization Act (MACRA) final rule is released in the fall.

Here are three key changes to Meaningful Use in the proposed rule:

  • 90-day reporting period in 2016.  The OPPS proposed rule would allow physicians, hospitals and critical access hospitals (CAH) to use any 90-day, continuous reporting period between Jan. 1 and Dec. 31, 2016, rather than the full calendar year reporting period currently required under Meaningful Use.

    CMS has also proposed a 90-day electronic health record (EHR) reporting period for clinical quality measures. However, the rule does not make any changes to the Physician Quality Reporting System (PQRS) reporting period, so if you are using clinical quality measures to satisfy PQRS reporting, you will still need to report clinical quality measures for a full calendar year in 2017.

  • Hardship exception for new participants.  CMS proposed 2017 as the first performance period for MACRA. But 2017 is also the last year first-time Meaningful Use participants may attest to avoid penalties in 2018.  The result is that a first-time participant would be required to report for both Meaningful Use and the Advancing Care Information (ACI) category under MIPS to avoid a payment adjustment 2018.

    In the OPPS proposed rule, however, CMS stated its intent to provide first-time participating physicians the opportunity to apply for a significant hardship exception from the 2018 payment adjustment.

    Physicians wishing to apply for the hardship exception will need to submit an application by Oct. 1, 2017, to demonstrate their eligibility. While the application has not yet been released, CMS indicates that it will require an explanation of why, based on the physician's particular circumstances, meeting requirements of the Meaningful Use program for the first time in 2017 while also reporting on measures for the ACI performance category of MIPS would result in significant hardship.

    The AMA pressed CMS for the hardship exception for 2017 and will continue to work toward making this process simple for physicians.

  • Changes to measures and threshold reductions.  CMS is also proposing to eliminate or reduce objectives and measures for eligible hospitals and CAHs attesting under the Meaningful Use program for calendar year 2017 and subsequent years.

    Some of these changes are intended to help align the hospital Meaningful Use program with MIPS when it is implemented beginning next year.

    For example, CMS proposed to eliminate the clinical decision support and computerized physician order entry objectives and measures for eligible hospitals and CAHs.  Additionally, the threshold for the health information exchange measure requiring physicians to create a summary of care will be reduced from more than 50 percent to more than 10 percent.

    The secure messaging threshold for eligible hospitals and CAHs will be reduced from more than 25 percent to more than 5 percent in Stage 3 because patients who are in the hospital for an isolated incident may not have a reason to follow up with the hospital via secure messaging.

For more information on these proposed changes, take a look at the OPPS proposed rule fact sheet from CMS.

   [return to top]

Court Case Examines Telemedicine Safety Regulations

A case before a United States Court of Appeals could restrict a state medical board from protecting patient safety through the regulation of telemedicine in that state.

At stake in Teladoc, Inc. v. Texas Medical Board is whether the Texas Medical Board has demonstrated immunity from federal antitrust laws. 

The Court of Appeals is being asked to determine whether the board may be held liable under the antitrust laws for its rule requiring a "defined physician-patient relationship to exist before a physician may prescribe dangerous or addictive medications. The necessary relationship is defined as established through either an in-person examination or an examination by electronic means with a health care professional present with the patient.

Teladoc, which uses telecommunications to connect patients and physicians, provides services in a way that would allow physicians to prescribe medications without the establishment of the required patient-physician relationship.  Teladoc alleges that if the Board's rule is valid, Teladoc would be limited in the way it could carry on business in Texas.  It contends that this rule is anticompetitive and seeks to hold the Board liable under federal antitrust laws.

Telemedicine is advancing rapidly as a tool to improve access to care and reduce the growth in health care spending.  Last month the AMA House of Delegates adopted new ethical ground rules for telemedicine.  But the telemedicine standards of care and practice guidelines are constantly evolving and vary based on specialty and the services provided. It is important that state medical boards remain free to regulate the practice of medicine to ensure patient safety and appropriate prescribing.

"Telemedicine offers significant potential benefits to patients, including expanded access to medical care," the Litigation Center of the AMA and State Medical Societies said in an amicus brief (log in).  "At the same time, telemedicine is inappropriate for certain medical conditions, and it carries risks. Because a physician treating a patient remotely may be called upon to act with limited information, the quality of care may suffer, and a potential exists for fraud and abuse."

"Given the complex and evolving state of telemedicine," the brief said, "Texas' balance of reliance on the expert board to act in the first instance, with state supervision as needed, is entirely appropriate—and should not be subject to second-guessing under the federal antitrust laws."

Read more at AMA Wire.
  [return to top]

Congress Enacts Comprehensive Addiction and Recovery Act (CARA)

At the end of last week, just before adjourning for the summer recess, the Senate passed the conference report of the Comprehensive Addiction & Recovery Act (CARA), sending the legislation addressing the nation's opioid problem to the President to be signed.  The White House has said President Obama will sign the bill, although there is no new funding to go along with the legislation.

Republicans and Democrats have not reached agreement about any additional funding for the law beyond what is proposed in each body's spending bills to fund the federal Department of Health and Human Services in the upcoming fiscal year.   While the Senate bill proposes a 93% increase over the current year's spending,  Democrats say that is still not enough to address the current crisis.

Items in the law of particular interest to Maine include the ability of Nurse Practitioners and Physician Assistants to prescribe Suboxone following appropriate education in those states where their scope of practice would permit the prescribing of controlled substances, which Maine law does permit.   It is hoped that passage of this bill will increase the supply of Suboxone prescribers in the state.



[return to top]

HHS Announces New Measures to Fight Opioid Epidemic

The U.S. Department of Health & Human Services announced last week several new actions the Department is taking to combat the nation's opioid epidemic.  

  • The rule finalized by the Substance Abuse & Mental Health Services Administration (SAMHSA) includes expanding access to buprenorphine; it allows clinicians who have had a waiver to prescribe buprenorphine for up to 100 patients for a year or more, to now obtain a waiver to treat up to 275 patients.  Clinicians are eligible to obtain the waiver if they have additional credentialing in addiction medicine or addiction psychiatry from a specialty medical board and/or professional society, or practice in a qualified setting as described in the rule.

  • The rule also includes a proposal to eliminate any potential financial incentive for physicians to prescribe opioids based on patient experience survey questions.  HHS states that this is an attempt to address physicians' and other health care providers' concerns that patient survey questions about pain management in the Hospital Value-Based Purchasing program unduly influence prescribing practices.

  • The rule will require Indian Health Service prescribers and pharmacists to check state PMP databases before prescribing or depending opioids for pain.

  • In addition, the department is launching more than a dozen new scientific studies on opioid misuse and pain treatment and soliciting feedback to improve and expand prescriber education and training programs.

The measures are intended to build on the HHS Opioid Initiative, which was launched in March 2015 and is focused on three key priorities:  1) improving opioid prescribing practices; 2) expanding access to medication-assisted treatment (MAT) for opioid use disorder; and 3) increasing the use of naloxone to reserve opioid overdoses.  They also build on the National Pain Strategy, the federal government's first coordinated plan to reduce the burden of chronic pain in the U.S.

It is hoped that these federal initiatives will support the several activities going on in Maine to also respond to the epidemic, including the recommendations of the Maine Opiate Collaborative and the work of the Caring for ME initiative developed by MMA and Quality Counts.

[return to top]

Maine Health Management Coalition and Maine Medical Association's 2016 Symposium

About the Symposium

For this year’s symposium we will be continuing to highlight and explore actionable strategies that each of us can take to help improve health and lower costs. Our keynote speaker, David Blumenthal, MD, President of The Commonwealth Fund, will share examples of how organizations around the country are getting more value from their health care dollars, and breakout sessions will dive into the details to highlight invidual efforts that organizations in our state can emulate. There will be presentations on tackling prescription drug abuse for providers and employers, alternative payment arrangements being tested through employer/provider partnerships, an overview of how MACRA will impact the payment landscape in our state, and more!


  • October 27, 2016
    8:00 AM - 5:00 PM
    Eastern Time

  • Holiday Inn by the Bay
    88 Spring Street
    Portland, Maine 04101

REGISTER AT: https://www.cvent.com/events/mhmc-mma-annual-symposium/registration-2518042715b34604b410c658a1a32973.aspx

[return to top]

Governors Sign Compact to Fight Opioid Addiction

Last week the governors of 46 states and territories signed “A Compact to Fight Opioid Addiction,” a series of commitment statements about the ongoing fight against opioid addiction.  The Compact contains several specific goals such as developing evidence-based opioid prescription guidelines, requiring ongoing prescriber education on pain management and addiction, reducing payment and administrative barriers to the use of opioid alternatives, and requiring the use of PMPs, prescription monitoring programs.  Many of these goals are included in Maine’s recent landmark opioid legislation, Public Law chapter 488.  The Compact also calls for pursuing overdose prevention and harm reduction strategies similar to those contained in Public Law chapter 508, which provides increased access to naloxone and contains “Good Samaritan” protections for providers.

Unfortunately, Maine’s Governor Paul LePage was not one of the governors signing the Compact.  Through a spokesperson, Governor LePage called the Compact a “feel-good measure” that fails to address the complete problem. He was particularly concerned that the Compact does not address law enforcement issues.

The governors also pledged to enhance communications strategies, particularly in schools and through social media, and to partner with professional associations “to improve understanding of the disease of addiction among health care providers and law enforcement.” In Maine, the Opiate Collaborative has been doing just that. Through its three task forces, Prevention/Harm Reduction, Treatment and Law Enforcement, the different prongs of the efforts to reduce opioid addiction have been communicating and working together to address the problem in a comprehensive manner. Maine has been a leader in that regard. LD 1646, the Governor’s bill which formed the basic structure and set the agenda for chapter 488, and the participation of the Maine Department of Public Safety in the work of the Collaborative in the area of law enforcement, are evidence of that leadership.

The governors who signed the compact have committed to review their work at the 2017 National Governors’ Association Winter Meeting and to build further on what they have accomplished by then.  At the same time, the Maine Medical Association looks forward to continuing its work in collaboration with Governor LePage’s administration and the Maine Legislature. We have already taken important steps together to deal with the problem of opioid addiction, and we can continue to do more by working together.

[return to top]

Job Openings

PRIMARY CARE PHYSICIAN - Eastern Maine Medical Center

Eastern Maine Medical Center seeks a primary care physician, board-certified/board-eligible in internal medicine, to join our well-established, quality-driven, outpatient practice. Husson Internal Medicine is one of seven primary care practices operated by Eastern Maine Medical Center. Our practice was the second in the nation to achieve “Patient-Centered Medical Home” status with NCQA. All physicians are NCQA-certified in diabetes and cardiac care. Our primary care network, largest in our area, has adopted a new practice model to include teams of one physician, one nurse practitioner, two registered nurses, and two medical assistants.   

Eastern Maine Medical Center is a 411-bed, regional, tertiary care and level II trauma center serving the more than 500,000 residents living in central, eastern, and northern Maine We offer a collegial atmosphere, cutting-edge EMR, generous vacation and CME benefit, flexible work schedule, and reasonable call schedule. No hospital call required. Candidates in need of J-1 visa waivers welcome to apply.  

For confidential consideration, please contact: Amanda Klausing Eastern Maine Medical Center Phone: 207-973-5358 emmccvs@emhs.org   


PHYSICIAN - Penobscot Community Health Care

Penobscot Community Health Care is seeking a Physician who is interested in working on a team dedicated to patient-centered care, innovation and collaboration for their Belfast location, Seaport Community Health Center. If this sounds like an opportunity you would be interested in, consider this:

You will be working on a team that has served its community for nearly 30 years!

You will be providing comprehensive, integrated primary health care services for an organization that exemplifies their Mission in everything they do.

You will be working on a team that recently achieved the highest level of recognition as a Patient-Centered Medical Home (PCMH) by the National Committee for Quality Assurance (NCQA).

You will be given the chance to make a difference in the lives of not only your patients, but the community you serve…every day.  

For more information, please contact Vanessa Sanderson, Recruitment Coordinator, Penobscot Community Health Center at (207) 404-8015 or vsanderson@pchc.com.



Nasson Health Care is seeking a qualified clinical leader to work collaboratively with a team of health and administrative professionals to provide comprehensive primary care to patients while utilizing the Patient-Centered Medical Home model of care delivery.  

The Physician/Medical Director: 

  • Provides advice and counsel regarding a broad range of clinical, clinical policy, programmatic and strategic issues required to achieve the short and long-term strategies and objectives of Nasson Health Care; 
  • Provides direct clinical services and oversees physicians and advanced practice nurses; works in partnership with members of the practice team to manage the care of patients, assuring a high standard of medical care; 

  Qualifications include:

  • A minimum of three years’ experience as a Medical Director of a primary care medical practice;  A degree from an accredited medical school in the U.S.,
  • Board certification in Family or Internal Medicine;  An unrestricted Maine license to practice medicine, as well as a U.S. Drug Enforcement Agency license;
  • Working knowledge of the core concepts of evidence-based practice, social and behavioral determinants of health, population-based care, integration of medical, behavioral health and dental care, and Meaningful Use of health information technology.

Visit http://www.nassonhealthcare.org for an application. Completed cover letter, resume, and employment application will be accepted until position is filled.


MEDICAL DIRECTOR SOUGHT for Mayo Regional Hospital Psychiatry and Counseling Clinic

Mayo Regional Hospital is seeking a part time Medical Director for its Psychiatry and Counseling clinic.  Mayo Psychiatry and Counseling provides mental health and substance abuse outpatient services, 5 days per week. The practice is staffed with a Director, Adult Psychiatrist, 2 PMHNP (child, adolescence and adult scope) and 7 clinicians.  The position would require 10-15 hours per week, with a combination on on-site and off-site work. Please contact, Lori Morrison, Vice President Physician Practices 207-564-4336 or lmorrison@mayohospital.com.


INTERNAL MEDICINE PHYSICIAN - Maine Medical Partners Internal Medical Clinic

Maine Medical Partners is seeking a PT BC/BE internal medicine physician for their Internal Medicine Outpatient Clinic at Maine Medical Center in Portland, Maine. 

The Clinic is the primary outpatient teaching site for Maine Medical Center’s Internal Medicine Residency Program and is the medical home for a culturally diverse population.  The ideal candidate will have an interest in residency education and international/immigrant patient care.  The clinical portion of the position involves a mix of direct patient care and the precepting of Internal Medicine Residents. 

Maine Medical Center has 637 licensed beds and is the state’s leading tertiary care hospital, with a full complement of residencies and fellowships and an integral part of Tufts University Medical School. 

For more information please contact Alison C. Nathanson, Director, MaineHealth Physician Recruitment Center at (207) 661-7383 or nathaa@mainehealth.org.



The Maine Highlands offers great outdoor adventures, historic and cultural experiences, many culinary delights and unexpected entertainment opportunities.  KVHC’s newest clinic, Brownville, is located in the Maine Highlands and Katahdin Region.  As a result of this continuous growth, Katahdin Valley Health Center is recruiting a Family Medicine/ Outpatient Internal Medicine Physician that is committed to providing quality health care services to the people in the Brownville/Millinocket Maine regions.   KVHC’s clinics are outpatient only and offers a four day work week with a competitive salary and benefit package which includes: a 10% of first year salary sign on bonus, generous amounts of paid time off and $2500 annually toward CME. Physicians who join KVHC are eligible to apply for NHSC Loan Repayment.  

To learn more about KVHC and Practitioner Opportunities, please contact Michelle LeFay at mlefay@kvhc.org or visit our website at www.kvhc.org.  KVHC is an equal opportunity employer.


[return to top]

Upcoming Events

163rd Annual Session

  September 9-11, 2016

Harborside Hotel - Bar Harbor, Maine

The theme of this year's program is "Renewing the Joy & Passion in Medicine."  For more information and to register click here


15th Annual Downeast Ophthalmology Symposium

September 23-26, 2016

Harborside Hotel - Bar Harbor, Maine

15 Hours Category 1 AMA PRA CME Credits Offered

Topics include Glaucoma, Cataract, and Uveitis.  Michael X. Repka, MD, MBA will deliver the Keynote address on Ophthalmology in an Era of Health Care Evolution.  There will also be time to enjoy the beautiful area!

For more information and to register visit: https://maineeyemds.com/symposium-home or contact Shirley Goggin at 207-445-2260 or sgoggin@mainemed.com.



MCMI Training Programs - Level 1 and Level 2

October 25, 2016

When and where held:  On October 25, 2016, the Maine Concussion Management Initiative will present Level 1 and Level 2 Training as the Youth Concussion Track at the Brain Injury Association of America-Maine Chapter's 7th Annual Conference on Defining Moments in Brain Injury in Portland at USM.

Training Programs:             

Level 1 – An Introduction to Concussions and Concussion Management

Speaker: Deb Nichols, CPNP or Peter Sedgwick, MD or Bill Heinz, MD

Level of Difficulty: beginner

Content:  The Diagnostic and Return to Play Dilemma, How Concussion Occurs and Pathophysiology, Concussion Signs and Symptoms, Concussion Evaluation Tools, Concussion Treatment, Recovery Epidemiology, Return to Function – Academics and Play, Risk Factors and Protective Equipment, Short and Long Term Sequelae, Neurocognitive Testing, Concussion Sideline Assessment, Key Points

Level 2 – Advanced Concussion Management (Level 1 is a prerequisite for taking Level 2)

Speaker: Paul Berkner, DO

Level of Difficulty: intermediate

Content: Updates from Zurich 2012, Using ImPACT Testing in Concussion Management, Interpreting   

ImPACT Test Results, Concussion Case Reviews

Schedule: Conference - 7:30pm to 4:30pm

MCMI Level 1: 9:30am to 1:00pm

MCMI Level 2: 1:30pm to 4:30pm                                                   


Fee: $100 for all participants for the entire day

How to register: online atwww.biausa.org then click on BIAA-Maine (in the menu on the left)

CMEs will be provided. Exact contact hours not determined at this time

For more information contact:

Jan Salis, PT, ATC, MCMI - Membership and Education Committee - Chair

jsalis@aol.com or (207) 577-2018




[return to top]

For more information or to contact us directly, please visit www.mainemed.com l ©2003, Maine Medical Association